ROS1 rearrangements occur in 1–2.6% of NSCLC patients [52,53] and are clinically associated with never-smoking history, younger age and adenocarcinoma histological type, frequently with brain metastases [51]. The gene discussed is ROS1; the disease is adenocarcinoma.